Clinical Pharmacology and Therapeutics - Table of Contents alert Volume 94 Issue 4

Advertisement Multiplexed Immunoassay Services for Inflammatory Biomarkers Myriad RBM provides quantitative, multiplexed immunoassay services for over 100 immune response and inflammatory biomarkers. Explore the utility of our service products and learn how your colleagues have applied our protein biomarker solutions to advance their development projects. Download the Application Notes TABLE OF CONTENTS Volume 94, Issue 4 (October 2013) In this issue In This Issue Editorial News & Views Perspectives Practice Regulation & Use State of the Art Review Research Also new AOP Sign up for CPT: Pharmacometrics & Systems Pharmacology e-alerts Sign up for e-alerts Recommend to your library Web feed Subscribe In This Issue Top In This Issue Clin Pharmacol Ther 2013 94: 413; 10.1038/clpt.2013.163 Full Text Editorial Top Heart Failure: A Disease Complex with Challenging Therapeutics J Vincent Clin Pharmacol Ther 2013 94: 415-421; 10.1038/clpt.2013.151 Abstract | Full Text News & Views Top HIGHLIGHTS Clin Pharmacol Ther 2013 94: 422-423; 10.1038/clpt.2013.162 Full Text ASCPT NEWS Clin Pharmacol Ther 2013 94: 424-427; 10.1038/clpt.2013.152 Full Text OBITUARY Paul Stanley Lietman, MD, PhD, 1934–2013 B G Petty and T A Shapiro Clin Pharmacol Ther 2013 94: 428-429; 10.1038/clpt.2013.156 Abstract | Full Text MACROSCOPY Heart Failure: An Update E Braunwald Clin Pharmacol Ther 2013 94: 430-432; 10.1038/clpt.2013.149 Full Text Perspectives Top COMMENTARIES Contemporary Use of Devices in Heart Failure A H Maass and D J van Veldhuisen Clin Pharmacol Ther 2013 94: 433-435; 10.1038/clpt.2013.144 Abstract | Full Text Do Anticoagulants or Antiplatelet Drugs Have a Role in Treating Heart Failure in the Absence of Atrial Fibrillation? P Gouda and J A Ezekowitz Clin Pharmacol Ther 2013 94: 435-438; 10.1038/clpt.2013.133 Abstract | Full Text Confidence in Generic Drug Substitution R Lionberger, W Jiang, S-M Huang and G Geba Clin Pharmacol Ther 2013 94: 438-440; 10.1038/clpt.2013.104 Abstract | Full Text Oral Anticancer Drugs: Back to Square One W Weitschies Clin Pharmacol Ther 2013 94: 441-442; 10.1038/clpt.2013.112 Abstract | Full Text LETTER TO THE EDITOR Pharmacogenetics in Transplant Patients: Mind the Mix M H ten Brink, T van der Straaten, H Bouwsma, R Baak-Pablo, H J Guchelaar and J J Swen Clin Pharmacol Ther 2013 94: 443-444; advance online publication, May 24, 2013; 10.1038/clpt.2013.110 Full Text Practice Top First-in-Class Angiotensin Receptor Neprilysin Inhibitor in Heart Failure O Vardeny, T Tacheny and S D Solomon Clin Pharmacol Ther 2013 94: 445-448; advance online publication, July 19, 2013; 10.1038/clpt.2013.146 Abstract | Full Text Regulation & Use Top PRACTICE Experience of a Vasopressin Receptor Antagonist, Tolvaptan, Under the Unique Indication in Japanese Heart Failure Patients K Kinugawa, T Imamura and I Komuro Clin Pharmacol Ther 2013 94: 449-451; advance online publication, July 19, 2013; 10.1038/clpt.2013.147 Full Text State of the Art Top CD34+ Stem Cell Therapy in Nonischemic Dilated Cardiomyopathy Patients B Vrtovec, G Poglajen, M Sever, L Lezaic, A Socan, F Haddad and J C Wu Clin Pharmacol Ther 2013 94: 452-458; advance online publication, July 31, 2013; 10.1038/clpt.2013.134 Abstract | Full Text Renin–Angiotensin–Aldosterone System Inhibitors in Heart Failure F Shearer, C C Lang and A D Struthers Clin Pharmacol Ther 2013 94: 459-467; advance online publication, July 12, 2013; 10.1038/clpt.2013.135 Abstract | Full Text Therapeutic Implications of Biomarkers in Chronic Heart Failure T Ahmad and C M O’Connor Clin Pharmacol Ther 2013 94: 468-479; advance online publication, July 15, 2013; 10.1038/clpt.2013.139 Abstract | Full Text MicroRNAs in Heart Failure: New Targets in Disease Management I Elzenaar, Y M Pinto and R J van Oort Clin Pharmacol Ther 2013 94: 480-489; advance online publication, July 12, 2013; 10.1038/clpt.2013.138 Abstract | Full Text Review Top Diuretic Use in Heart Failure and Outcomes T G von Lueder, D Atar and H Krum Clin Pharmacol Ther 2013 94: 490-498; advance online publication, July 12, 2013; 10.1038/clpt.2013.140 Abstract | Full Text Pharmacological Treatment of Acute Heart Failure: Current Treatment and New Targets J Pöss, A Link and M Böhm Clin Pharmacol Ther 2013 94: 499-508; advance online publication, November 17, 2013; 10.1038/clpt.2013.136 Abstract | Full Text The High-Risk Patient With Heart Failure With Reduced Ejection Fraction: Treatment Options and Challenges J A Bartos and G S Francis Clin Pharmacol Ther 2013 94: 509-518; advance online publication, July 12, 2013; 10.1038/clpt.2013.137 Abstract | Full Text Research Top ARTICLES Interchangeability of Gabapentin Generic Formulations in the Netherlands: A Comparative Bioavailability Study Y Yu, S Teerenstra, F Vanmolkot, C Neef, D Burger and M Maliepaard Clin Pharmacol Ther 2013 94: 519-524; advance online publication, May 24, 2013; 10.1038/clpt.2013.108 Abstract | Full Text Purine Pathway Implicated in Mechanism of Resistance to Aspirin Therapy: Pharmacometabolomics-Informed Pharmacogenomics L M Yerges-Armstrong, S Ellero-Simatos, A Georgiades, H Zhu, J p Lewis, R B Horenstein, A L Beitelshees, A Dane, T Reijmers, T Hankemeier, O Fiehn, A R Shuldiner and R Kaddurah-Daouk ; Pharmacometabolomics Research Network Clin Pharmacol Ther 2013 94: 525-532; advance online publication, June 11, 2013; 10.1038/clpt.2013.119 Abstract | Full Text Profiling Serum Bile Acid Glucuronides in Humans: Gender Divergences, Genetic Determinants, and Response to Fenofibrate J Trottier, M Perreault, I Rudkowska, C Levy, A Dallaire-Theroux, M Verreault, P Caron, B Staels, M-C Vohl, R J Straka and O Barbier Clin Pharmacol Ther 2013 94: 533-543; advance online publication, June 12, 2013; 10.1038/clpt.2013.122 Abstract | Full Text Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Clinical Pharmacology & Therapeutics. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.